Abu Dhabi, United Arab Emirates
+919405476170
+919405476170

Buy Svitinib 12.5mg in UAE | Ernest Oncology – Oncology Meds Supplier

Svitinib 12.5mg Capsule: A Breakthrough in Targeted Multi-Kinase Inhibition for Oncology


Are you looking for a reliable Svitinib 12.5 mg capsule exporter from India? Ernest Oncology, a dedicated division of Ernest Pharmaceutical Pvt. Ltd., stands as a premier global supplier and bulk distributor of advanced oncology therapeutics. We serve critical healthcare markets in the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, ensuring that high-quality cancer care is accessible through streamlined B2B pharmaceutical exports.




Detailed Product Information: What is Svitinib 12.5 mg?


Svitinib 12.5 mg is an oral targeted therapy medication containing the active ingredient Sunitinib Malate. It belongs to a sophisticated class of drugs known as Tyrosine Kinase Inhibitors (TKIs).

Unlike conventional chemotherapy, which can impact all rapidly dividing cells in the body, Svitinib is designed to interfere with specific signaling pathways that cancer cells use to survive and multiply. By targeting these specific molecular markers, it provides a more focused approach to cancer treatment.



Primary Therapeutic Indications:

Svitinib 12.5 mg is clinically utilized for several difficult-to-treat malignancies:

  • Advanced Renal Cell Carcinoma (RCC): Used as a primary treatment for patients with advanced or metastatic kidney cancer.

  • Gastrointestinal Stromal Tumors (GIST): Indicated for the treatment of tumors in the stomach or intestines, specifically for patients who have not responded to or cannot tolerate other therapies (like imatinib).

  • Pancreatic Neuroendocrine Tumors (pNET): Used for progressive, well-differentiated tumors originating in the hormone-producing cells of the pancreas.

  • Adjuvant RCC Treatment: To prevent the recurrence of kidney cancer in patients who are at high risk after having surgery to remove the kidney.



Mechanism of Action: How Svitinib 12.5 mg Works :

Svitinib works by simultaneously blocking multiple receptor tyrosine kinases (RTKs) that are overactive in certain tumors.

  1. Anti-Angiogenesis: It inhibits VEGFR (Vascular Endothelial Growth Factor receptors). This prevents the tumor from growing new blood vessels, essentially "starving" the tumor of the oxygen and nutrients it needs to expand.

  2. Proliferation Blockage: It targets PDGFR (Platelet-Derived Growth Factor Receptors) and KIT, which are critical signaling proteins that tell cancer cells to divide and grow.

  3. Metastasis Inhibition: By disrupting these vital cellular communication lines, Svitinib helps to slow down the progression of the disease and prevents the cancer from spreading to other parts of the body.



Dosage, Administration, and Safety: 

  • Administration: Svitinib 12.5 mg is taken orally. It can be consumed with or without food.

  • The 4/2 Schedule: For RCC and GIST, a common cycle involves taking the medication daily for 4 weeks, followed by a 2-week rest period.

  • Continuous Dosing: For pancreatic neuroendocrine tumors, the medication is often taken daily without a rest period.

  • Crucial Precaution: Patients must avoid grapefruit and grapefruit juice while on Svitinib, as it can significantly increase the drug's concentration in the bloodstream to toxic levels.


Common Side Effects & Monitoring: 

Medical professionals must monitor patients for potential side effects, including the following:

  • Fatigue and weakness.

  • Hand-Foot Syndrome: Skin redness, swelling, or pain on the palms and soles.

  • Hypertension (High Blood Pressure).

  • Changes in skin color or hair color.

  • Nausea and diarrhea.


Why Choose Ernest Oncology for Global Svitinib Supply?

  • Expert Export Logistics: We manage the complexities of international shipping to USA, UK, UAE, Australia, and South Africa. 

  • Authentic Indian Sourcing: As a leading exporter from India, we source products from GMP-compliant manufacturers to ensure the highest safety standards.

  • Bulk Availability: We maintain a consistent inventory of 12.5mg, 25mg, and 50mg strengths for hospital and clinical requirements.

  • Competitive B2B Support: We offer optimized pricing structures for international distributors and oncology centers.


Contact Ernest Oncology—Pharmaceutical Exporter from India

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD]

 2026-03-25T08:56:06

Keywords